Perrigo (PRGO) to Release Earnings on Friday

Perrigo (NYSE:PRGO) will post its earnings results before the market opens on Friday, August 2nd. Analysts expect Perrigo to post earnings of $0.52 per share for the quarter. Investors interested in participating in the company’s conference call can do so using this link.

Perrigo (NYSE:PRGO) last issued its earnings results on Saturday, May 4th. The company reported $0.29 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.23 by $0.06. The firm had revenue of $1.08 billion for the quarter, compared to analyst estimates of $1.09 billion. Perrigo had a positive return on equity of 6.96% and a negative net margin of 0.17%. The business’s revenue was down 8.4% on a year-over-year basis. During the same period in the previous year, the company posted $0.45 earnings per share. On average, analysts expect Perrigo to post $3 EPS for the current fiscal year and $3 EPS for the next fiscal year.

Perrigo Stock Down 0.1 %

PRGO stock opened at $28.26 on Thursday. Perrigo has a fifty-two week low of $24.82 and a fifty-two week high of $40.28. The stock has a fifty day moving average of $27.00 and a 200-day moving average of $29.72. The company has a market capitalization of $3.85 billion, a price-to-earnings ratio of -403.71 and a beta of 0.51. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.08 and a current ratio of 1.81.

Insider Transactions at Perrigo

In other Perrigo news, EVP Svend Andersen acquired 1,000 shares of the company’s stock in a transaction that occurred on Tuesday, May 28th. The stock was bought at an average price of $27.90 per share, with a total value of $27,900.00. Following the completion of the purchase, the executive vice president now owns 101,853 shares of the company’s stock, valued at $2,841,698.70. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 0.70% of the company’s stock.

Analysts Set New Price Targets

Several research firms have recently issued reports on PRGO. StockNews.com lowered shares of Perrigo from a “buy” rating to a “hold” rating in a research report on Tuesday, July 23rd. Piper Sandler cut their price target on Perrigo from $36.00 to $35.00 and set an “overweight” rating for the company in a report on Thursday, July 11th. Finally, Canaccord Genuity Group restated a “buy” rating and issued a $42.00 target price on shares of Perrigo in a research note on Friday, April 12th.

About Perrigo

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.